Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 18 studies | 21% ± 4% | |
memory B cell | 15 studies | 27% ± 8% |
Insufficient scRNA-seq data for expression of AIM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 116.37 | 569 / 578 | 76% | 17.73 | 877 / 1155 |
bladder | 81% | 81.43 | 17 / 21 | 59% | 29.30 | 298 / 504 |
esophagus | 76% | 64.17 | 1103 / 1445 | 54% | 15.71 | 99 / 183 |
uterus | 52% | 20.19 | 89 / 170 | 64% | 40.37 | 295 / 459 |
intestine | 76% | 322.18 | 735 / 966 | 36% | 5.74 | 189 / 527 |
breast | 73% | 36.72 | 334 / 459 | 35% | 3.80 | 386 / 1118 |
stomach | 64% | 41.57 | 229 / 359 | 42% | 7.34 | 120 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 183.42 | 29 / 29 |
spleen | 100% | 1860.92 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1175.59 | 918 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 50.44 | 41 / 45 |
skin | 23% | 9.74 | 408 / 1809 | 64% | 23.08 | 303 / 472 |
adipose | 75% | 46.51 | 908 / 1204 | 0% | 0 | 0 / 0 |
brain | 38% | 16.41 | 1005 / 2642 | 32% | 1.98 | 228 / 705 |
prostate | 63% | 45.86 | 155 / 245 | 6% | 0.35 | 29 / 502 |
kidney | 40% | 34.27 | 36 / 89 | 27% | 2.50 | 245 / 901 |
thymus | 40% | 59.49 | 260 / 653 | 18% | 1.89 | 106 / 605 |
pancreas | 8% | 2.31 | 26 / 328 | 43% | 6.41 | 77 / 178 |
liver | 33% | 13.98 | 74 / 226 | 10% | 1.11 | 41 / 406 |
ovary | 17% | 6.82 | 31 / 180 | 24% | 1.57 | 103 / 430 |
blood vessel | 38% | 25.56 | 512 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 30% | 10.31 | 78 / 258 | 4% | 1.81 | 9 / 230 |
heart | 10% | 4.37 | 83 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.40 | 6 / 80 |
muscle | 3% | 0.85 | 21 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043029 | Biological process | T cell homeostasis |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_1904270 | Biological process | pyroptosome complex assembly |
GO_0051607 | Biological process | defense response to virus |
GO_0006974 | Biological process | DNA damage response |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0050795 | Biological process | regulation of behavior |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0006955 | Biological process | immune response |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_0140970 | Biological process | AIM2 inflammasome complex assembly |
GO_2001056 | Biological process | positive regulation of cysteine-type endopeptidase activity |
GO_0002218 | Biological process | activation of innate immune response |
GO_0007420 | Biological process | brain development |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0097169 | Cellular component | AIM2 inflammasome complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0035861 | Cellular component | site of double-strand break |
GO_0038187 | Molecular function | pattern recognition receptor activity |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0140608 | Molecular function | cysteine-type endopeptidase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AIM2 |
Protein name | Alternative protein AIM2 Interferon-inducible protein AIM2 (Absent in melanoma 2) Absent in melanoma 2 |
Synonyms | |
Description | FUNCTION: Sensor component of the AIM2 inflammasome, which mediates inflammasome activation in response to the presence of double-stranded DNA (dsDNA) in the cytosol, leading to subsequent pyroptosis . Inflammasomes are supramolecular complexes that assemble in the cytosol in response to pathogens and other damage-associated signals and play critical roles in innate immunity and inflammation . Acts as a recognition receptor (PRR): specifically recognizes and binds dsDNA in the cytosol, and mediates the formation of the inflammasome polymeric complex composed of AIM2, CASP1 and PYCARD/ASC . Recruitment of pro-caspase-1 (proCASP1) to the AIM2 inflammasome promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), promoting cytokine secretion . In some cells, CASP1 activation mediates cleavage and activation of GSDMD, triggering pyroptosis without promoting cytokine secretion . Detects cytosolic dsDNA of viral and bacterial origin in a non-sequence-specific manner . Involved in the DNA damage response caused by acute ionizing radiation by mediating pyroptosis of intestinal epithelial cells and bone marrow cells in response to double-strand DNA breaks (By similarity). Mechanistically, AIM2 senses DNA damage in the nucleus to mediate inflammasome assembly and inflammatory cell death (By similarity). Also acts as a regulator of neurodevelopment via its role in the DNA damage response: acts by promoting neural cell death in response to DNA damage in the developing brain, thereby purging genetically compromised cells of the central nervous system (By similarity). Pyroptosis mediated by the AIM2 inflammasome in response to DNA damage is dependent on GSDMD without involving IL1B and IL18 cytokine secretion (By similarity). Also acts as a mediator of pyroptosis, necroptosis and apoptosis (PANoptosis), an integral part of host defense against pathogens, in response to bacterial infection (By similarity). Can also trigger PYCARD/ASC-dependent, caspase-1-independent cell death that involves caspase-8 (CASP8) (By similarity). .; FUNCTION: Also acts as a tumor suppressor independently of its role in inflammatory response . Able to suppress overt cell proliferation in enterocytes: restricts stem cell proliferation in the intestinal mucosa in an inflammasome-independent manner, contributing to a decrease in the likelihood of colorectal cancer development (By similarity). AIM2 suppresses cell proliferation by inhibiting phosphorylation of AKT1 at 'Ser-473', preventing AKT1 activation and AKT-mTOR signaling pathway (By similarity). Inhibits AKT1 phosphorylation both by inhibiting the activity of PRKDC/DNA-PK kinase and promoting dephosphorylation by PP2A phosphatase (By similarity). Also acts as a key regulator of regulatory T-cells (Treg) homeostasis by promoting their stability: acts by preventing AKT1 activation (By similarity). Its role in Treg homeostasis is important to restain autoimmune diseases (By similarity). . |
Accessions | L8E7Q5 ENST00000368129.3 Q5T3W0 O14862 ENST00000368130.9 ENST00000695580.1 A0A8Q3WLZ2 ENST00000695579.1 ENST00000411768.2 |